OPR - Delayed Quote • USD PRGO Jan 2025 27.500 call (PRGO250117C00027500) Follow 5.90 0.00 (0.00%) At close: April 19 at 2:07 PM EDT Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for PRGO250117C00027500 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: PRGO Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024 Here’s Why Perrigo Company PLC (PRGO) Stock Slumped in Q1 The WNBA has partnered with Glossier and Skims—now it’s added Opill, the new over-the-counter birth control Opill and WNBA Team Up for Groundbreaking Partnership CVS Caremark to cover Perrigo's birth control pill in US at zero cost for plan sponsors Why Is Perrigo (PRGO) Up 19.1% Since Last Earnings Report? Prepare for Takeoff With Perrigo Perrigo Company plc (NYSE:PRGO) Q4 2023 Earnings Call Transcript First over-the-counter birth control pill in US begins shipping to stores Over-the-Counter Birth Control Pill to Be Available Within Weeks on Retail Shelves Perrigo Commences Shipments of Opill® to Retailers Nationwide, Empowering Millions to Enter a New Era of Reproductive Health Access in the United States
